Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study

<p>Abstract</p> <p>Background</p> <p>Procalcitonin (PCT) has emerged as a valuable marker of sepsis. The potential role of PCT in diagnosis and therapy monitoring of intravascular catheter-related bloodstream infections (CRBSI) in intensive care unit (ICU) is still uncl...

Full description

Bibliographic Details
Main Authors: Theodorou Vasiliki P, Papaioannou Vasilios E, Tripsianis Gregory A, Panopoulou Maria K, Christophoridis Elias K, Kouliatsis Georgios A, Gioka Theodora M, Maltezos Efstratios S, Ktenidou-Kartali Sophia I, Pneumatikos Ioannis A
Format: Article
Language:English
Published: BMC 2012-10-01
Series:BMC Infectious Diseases
Online Access:http://www.biomedcentral.com/1471-2334/12/247
id doaj-19a46a1feec34508b2fa06489ee2a6c0
record_format Article
spelling doaj-19a46a1feec34508b2fa06489ee2a6c02020-11-25T03:42:59ZengBMCBMC Infectious Diseases1471-23342012-10-0112124710.1186/1471-2334-12-247Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational studyTheodorou Vasiliki PPapaioannou Vasilios ETripsianis Gregory APanopoulou Maria KChristophoridis Elias KKouliatsis Georgios AGioka Theodora MMaltezos Efstratios SKtenidou-Kartali Sophia IPneumatikos Ioannis A<p>Abstract</p> <p>Background</p> <p>Procalcitonin (PCT) has emerged as a valuable marker of sepsis. The potential role of PCT in diagnosis and therapy monitoring of intravascular catheter-related bloodstream infections (CRBSI) in intensive care unit (ICU) is still unclear and was evaluated.</p> <p>Methods</p> <p>Forty-six patients were included in the study, provided they were free of infection upon admission and presented the first episode of suspected CRBSI during their ICU stay. Patients who had developed any other infection were excluded. PCT was measured daily during the ICU hospitalization. Primary endpoint was proven CRBSI. Therapy monitoring as according to infection control was also evaluated.</p> <p>Results</p> <p>Among the 46 patients, 26 were diagnosed with CRBSI. Median PCT on the day of infection suspicion (D0) was 7.70 and 0.10 ng/ml for patients with and without proven CRBSI, respectively (p < 0.001). The area under the curve (AUC) for PCT was 0.990 (95% CI; 0.972 – 1.000), whereas a cut-off value of 0.70 ng/ml provided sensitivity and specificity of 92.3 and 100% respectively. In contrast, the AUC for white blood cells (WBC) was 0.539 (95% CI; 0.369 – 0.709), and for C-reactive protein (CRP), 0.603 (95% CI; 0.438 – 0.768). PCT was the best predictor of proven infection. Moreover, an increase >0.20 ng/ml of PCT between the D0 and any of the 4 preceding days was associated with a positive predictive value exceeding 96%. PCT concentrations from the D2 to D6 after suspected infection tended to decrease in controlled patients, whereas remained stable in non-controlled subjects. A PCT concentration exceeding 1.5 ng/ml during D3 was associated with lack of responsiveness to therapy (p = 0.028).</p> <p>Conclusions</p> <p>We suggest that PCT could be a helpful diagnostic and prognostic marker of CRBSI in critically ill patients. Both absolute values and variations should be considered.</p> http://www.biomedcentral.com/1471-2334/12/247
collection DOAJ
language English
format Article
sources DOAJ
author Theodorou Vasiliki P
Papaioannou Vasilios E
Tripsianis Gregory A
Panopoulou Maria K
Christophoridis Elias K
Kouliatsis Georgios A
Gioka Theodora M
Maltezos Efstratios S
Ktenidou-Kartali Sophia I
Pneumatikos Ioannis A
spellingShingle Theodorou Vasiliki P
Papaioannou Vasilios E
Tripsianis Gregory A
Panopoulou Maria K
Christophoridis Elias K
Kouliatsis Georgios A
Gioka Theodora M
Maltezos Efstratios S
Ktenidou-Kartali Sophia I
Pneumatikos Ioannis A
Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
BMC Infectious Diseases
author_facet Theodorou Vasiliki P
Papaioannou Vasilios E
Tripsianis Gregory A
Panopoulou Maria K
Christophoridis Elias K
Kouliatsis Georgios A
Gioka Theodora M
Maltezos Efstratios S
Ktenidou-Kartali Sophia I
Pneumatikos Ioannis A
author_sort Theodorou Vasiliki P
title Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
title_short Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
title_full Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
title_fullStr Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
title_full_unstemmed Procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
title_sort procalcitonin and procalcitonin kinetics for diagnosis and prognosis of intravascular catheter-related bloodstream infections in selected critically ill patients: a prospective observational study
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2012-10-01
description <p>Abstract</p> <p>Background</p> <p>Procalcitonin (PCT) has emerged as a valuable marker of sepsis. The potential role of PCT in diagnosis and therapy monitoring of intravascular catheter-related bloodstream infections (CRBSI) in intensive care unit (ICU) is still unclear and was evaluated.</p> <p>Methods</p> <p>Forty-six patients were included in the study, provided they were free of infection upon admission and presented the first episode of suspected CRBSI during their ICU stay. Patients who had developed any other infection were excluded. PCT was measured daily during the ICU hospitalization. Primary endpoint was proven CRBSI. Therapy monitoring as according to infection control was also evaluated.</p> <p>Results</p> <p>Among the 46 patients, 26 were diagnosed with CRBSI. Median PCT on the day of infection suspicion (D0) was 7.70 and 0.10 ng/ml for patients with and without proven CRBSI, respectively (p < 0.001). The area under the curve (AUC) for PCT was 0.990 (95% CI; 0.972 – 1.000), whereas a cut-off value of 0.70 ng/ml provided sensitivity and specificity of 92.3 and 100% respectively. In contrast, the AUC for white blood cells (WBC) was 0.539 (95% CI; 0.369 – 0.709), and for C-reactive protein (CRP), 0.603 (95% CI; 0.438 – 0.768). PCT was the best predictor of proven infection. Moreover, an increase >0.20 ng/ml of PCT between the D0 and any of the 4 preceding days was associated with a positive predictive value exceeding 96%. PCT concentrations from the D2 to D6 after suspected infection tended to decrease in controlled patients, whereas remained stable in non-controlled subjects. A PCT concentration exceeding 1.5 ng/ml during D3 was associated with lack of responsiveness to therapy (p = 0.028).</p> <p>Conclusions</p> <p>We suggest that PCT could be a helpful diagnostic and prognostic marker of CRBSI in critically ill patients. Both absolute values and variations should be considered.</p>
url http://www.biomedcentral.com/1471-2334/12/247
work_keys_str_mv AT theodorouvasilikip procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT papaioannouvasiliose procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT tripsianisgregorya procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT panopouloumariak procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT christophoridiseliask procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT kouliatsisgeorgiosa procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT giokatheodoram procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT maltezosefstratioss procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT ktenidoukartalisophiai procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
AT pneumatikosioannisa procalcitoninandprocalcitoninkineticsfordiagnosisandprognosisofintravascularcatheterrelatedbloodstreaminfectionsinselectedcriticallyillpatientsaprospectiveobservationalstudy
_version_ 1724522132647444480